Geraldine Venthoy
Executive Vice President
Pharmaceutical Development
vectura.
Switzerland
Biography
Ms. Geraldine Venthoye is Executive Vice President - Pharmaceutical Development Appointment of the company. Dr Geraldine Venthoye joined Vectura in June 2016 upon completion of the merger with Skyepharma PLC, where she had been executive vice president Pharmaceutical Development since 2013, having joined Skyepharma as Head of inhalation business unit in September 2003. Geraldine is a UK registered pharmacist and holds a doctorate degree in pharmaceutics from the University of London. Geraldine held senior CMC leadership and scientific roles in Inhale/ Nektar Therapeutics, San Carlos, California, US, and prior to this in the UK, held scientific positions in inhalation drug delivery at Vandsons Research and Norton Healthcare.
Research Interest
pharmaceutics
